Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.

Banach M, Bruckert E, Descamps OS, Ellegård L, Ezhov M, Föger B, Fras Z, Kovanen PT, Latkovskis G, März W, Panagiotakos DB, Paragh G, Pella D, Pirillo A, Poli A, Reiner Ž, Silbernagel G, Viigimaa M, Vrablík M, Catapano AL.

Atheroscler Suppl. 2019 Aug 17. pii: S1567-5688(19)30046-7. doi: 10.1016/j.atherosclerosissup.2019.08.023. [Epub ahead of print] No abstract available.

PMID:
31451336
2.

Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials.

Fogacci F, Banach M, Mikhailidis DP, Bruckert E, Toth PP, Watts GF, Reiner Ž, Mancini J, Rizzo M, Mitchenko O, Pella D, Fras Z, Sahebkar A, Vrablik M, Cicero AFG; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP).

Pharmacol Res. 2019 May;143:1-16. doi: 10.1016/j.phrs.2019.02.028. Epub 2019 Mar 4. Review.

PMID:
30844537
3.

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome.

Singh RB, Fedacko J, Mojto V, Pella D.

Antioxidants (Basel). 2018 Jul 25;7(8). pii: E99. doi: 10.3390/antiox7080099.

4.

Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.

Petrikova J, Janicko M, Fedacko J, Drazilova S, Madarasova Geckova A, Marekova M, Pella D, Jarcuska P.

Int J Environ Res Public Health. 2018 Jul 4;15(7). pii: E1412. doi: 10.3390/ijerph15071412.

5.

The Role of Nutraceuticals in Statin Intolerant Patients.

Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, Vrablík M, Watts GF, Wong ND, Rizzo M; International Lipid Expert Panel (ILEP).

J Am Coll Cardiol. 2018 Jul 3;72(1):96-118. doi: 10.1016/j.jacc.2018.04.040. Review.

6.

Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia.

Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, Madarasova-Geckova A, Marekova M, Pella D, Jarcuska P; HepaMeta Team.

Int J Environ Res Public Health. 2018 May 22;15(5). pii: E1047. doi: 10.3390/ijerph15051047.

7.

Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia.

Halánová M, Veseliny E, Kalinová Z, Jarčuška P, Janičko M, Urbančíková I, Pella D, Dražilová S, Babinská I; HepaMeta Team.

Int J Environ Res Public Health. 2018 May 3;15(5). pii: E904. doi: 10.3390/ijerph15050904.

8.

Age-adjusted Mortality Rates of Neoplasms and Circulatory System Diseases and Their Demographic Factors in Slovak Regions during 1996-2013.

Pella D, Fedačko J, Rajnoha R, Gavurová B, Koróny S.

Cent Eur J Public Health. 2017 Dec;25 Suppl 2:S86-S93. doi: 10.21101/cejph.a5056.

9.
10.

Exposure to Toxoplasma gondii in the Roma and Non-Roma Inhabitants of Slovakia: A Cross-Sectional Seroprevalence Study.

Antolová D, Janičko M, Halánová M, Jarčuška P, Gecková AM, Babinská I, Kalinová Z, Pella D, Mareková M, Veseliny E; HepaMeta Team.

Int J Environ Res Public Health. 2018 Feb 27;15(3). pii: E408. doi: 10.3390/ijerph15030408.

11.

A Community-Based Study to Estimate the Seroprevalence of Trichinellosis and Echinococcosis in the Roma and Non-Roma Population of Slovakia.

Antolová D, Halánová M, Janičko M, Jarčuška P, Reiterová K, Jarošová J, Madarasová Gecková A, Pella D, Dražilová S; HepaMeta Team.

Int J Environ Res Public Health. 2018 Feb 2;15(2). pii: E251. doi: 10.3390/ijerph15020251.

12.

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease.

Hagström E, Norlund F, Stebbins A, Armstrong PW, Chiswell K, Granger CB, López-Sendón J, Pella D, Soffer J, Sy R, Wallentin L, White HD, Stewart RAH, Held C.

J Intern Med. 2018 Jan;283(1):83-92. doi: 10.1111/joim.12692. Epub 2017 Oct 23.

PMID:
28960596
13.

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Nutr Rev. 2017 Sep 1;75(9):731-767. doi: 10.1093/nutrit/nux047. Review.

PMID:
28938795
14.

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Arch Med Sci. 2017 Aug;13(5):965-1005. doi: 10.5114/aoms.2017.69326. Epub 2017 Aug 4. No abstract available.

15.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

16.

Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients.

Tóth Š, Fedačko J, Pekárová T, Hertelyová Z, Katz M, Mughees A, Kuzma J, Štefanič P, Kopolovets I, Pella D.

Cardiol Ther. 2017 Dec;6(2):281-289. doi: 10.1007/s40119-017-0092-8. Epub 2017 Jun 16.

17.

Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia.

Tóth Š, Šajty M, Pekárová T, Mughees A, Štefanič P, Katz M, Spišáková K, Pella J, Pella D.

J Basic Clin Physiol Pharmacol. 2017 Jul 26;28(4):327-336. doi: 10.1515/jbcpp-2016-0149.

PMID:
28541926
18.

Rare Presentation of Left Lower Lobe Pulmonary Artery Dissection.

Hako R, Fedačko J, Tóth Š, Morochovič R, Kristian P, Pekárová T, Tuomainen P, Pella D.

Case Rep Med. 2017;2017:2760535. doi: 10.1155/2017/2760535. Epub 2017 Jan 5.

19.

Extended consensus on blood pressure variability beyond blood pressure for management of hypertension.

Singh RB, Hristova K, Bjørklund G, Fedacko J, Chirumbolo S, Pella D.

J Am Soc Hypertens. 2017 Jan;11(1):6-9. doi: 10.1016/j.jash.2016.11.005. Epub 2016 Nov 25. No abstract available.

PMID:
28040405
20.

Pleiotropic effects of statins in the diseases of the liver.

Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P.

World J Gastroenterol. 2016 Jul 21;22(27):6201-13. doi: 10.3748/wjg.v22.i27.6201. Review.

Supplemental Content

Loading ...
Support Center